Please Note: This trial is no longer enrolling new participants
The High-Dose Aldesleukin (IL-2) "SELECT" Trial: A Prospective Tissue Collection Protocol to Investigate Predictive Models of Response to High Dose IL-2 Treatment in Patients with Advanced Melanoma
| Protocol No. | 09-333 | Scope | National |
|---|---|---|---|
| Principal Investigator | Theodore Logan | Treatment Type | Basic Science |
| Age Group | Adult | Phase | NA |
